Literature DB >> 16791199

Nanog promotes transfer of pluripotency after cell fusion.

José Silva1, Ian Chambers, Steven Pollard, Austin Smith.   

Abstract

Through cell fusion, embryonic stem (ES) cells can erase the developmental programming of differentiated cell nuclei and impose pluripotency. Molecules that mediate this conversion should be identifiable in ES cells. One candidate is the variant homeodomain protein Nanog, which has the capacity to entrain undifferentiated ES cell propagation. Here we report that in fusions between ES cells and neural stem (NS) cells, increased levels of Nanog stimulate pluripotent gene activation from the somatic cell genome and enable an up to 200-fold increase in the recovery of hybrid colonies, all of which show ES cell characteristics. Nanog also improves hybrid yield when thymocytes or fibroblasts are fused to ES cells; however, fewer colonies are obtained than from ES x NS cell fusions, consistent with a hierarchical susceptibility to reprogramming among somatic cell types. Notably, for NS x ES cell fusions elevated Nanog enables primary hybrids to develop into ES cell colonies with identical frequency to homotypic ES x ES fusion products. This means that in hybrids, increased Nanog is sufficient for the NS cell epigenome to be reset completely to a state of pluripotency. We conclude that Nanog can orchestrate ES cell machinery to instate pluripotency with an efficiency of up to 100% depending on the differentiation status of the somatic cell.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791199     DOI: 10.1038/nature04914

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  124 in total

Review 1.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 2.  The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.

Authors:  Eriona Hysolli; Yong Wook Jung; Yoshiaki Tanaka; Kun-Yong Kim; In-Hyun Park
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 3.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

4.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 5.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

6.  Polyploidization of 2nH1 (ES) cells by K-252a and staurosporine.

Authors:  Kohzaburo Fujikawa-Yamamoto; Minoru Miyagoshi; Hiroko Yamagishi
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

7.  The flawed scientific basis of the altered nuclear transfer-oocyte assisted reprogramming (ANT-OAR) proposal.

Authors:  W Malcolm Byrnes
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

Review 8.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

9.  Mitochondrial translocation of p53 modulates neuronal fate by preventing differentiation-induced mitochondrial stress.

Authors:  Joana M Xavier; Ana L Morgado; Susana Solá; Cecília M P Rodrigues
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

10.  Tauroursodeoxycholic acid increases neural stem cell pool and neuronal conversion by regulating mitochondria-cell cycle retrograde signaling.

Authors:  Joana M Xavier; Ana L Morgado; Cecília Mp Rodrigues; Susana Solá
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.